RS Camplejohn
Impact in
- Cancer Research top 5%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
- Oncology top 5%
- Cancer-related Molecular Pathways
- HER2/EGFR in Cancer Research
- Cancer Cells and Metastasis
Papers in
- Oncology 15
- Cancer-related Molecular Pathways 6
- HER2/EGFR in Cancer Research 4
- Cutaneous Melanoma Detection and Management 2
-
- Breast Lesions and Carcinomas 3
- Lymphoma Diagnosis and Treatment 3
- Genetic factors in colorectal cancer 3
- Co-authors
- R. A. Walker (1 shared paper)DM Barnes (5 shared papers)D M Barnes (3 shared papers)R R Millis (3 shared papers)Jiřina Bártková (2 shared papers)MA Richards (2 shared papers)Martine E. Lomax (2 shared papers)Steven M. Picksley (2 shared papers)
- Journals
- British Journal of Cancer (10 papers)Oncogene (3 papers)British Journal of Dermatology (3 papers)Clinical Oncology (2 papers)Histopathology (1 paper)
- Partner nations
- United KingdomThailandCanada
In The Last Decade
RS Camplejohn
27 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 82
- Cancer Research 378
- Oncology 664
- Pathology and Forensic Medicine 219
- Radiology, Nuclear Medicine and Imaging 180
- Molecular Biology 416
Countries citing papers authored by RS Camplejohn
This map shows the geographic impact of RS Camplejohn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by RS Camplejohn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites RS Camplejohn more than expected).
Fields of papers citing papers by RS Camplejohn
This network shows the impact of papers produced by RS Camplejohn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by RS Camplejohn. The network helps show where RS Camplejohn may publish in the future.
Co-authors
The 25 scholars most cited alongside RS Camplejohn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1991 | 137 | |
| 2 | 1991 | 125 | |
| 3 | 1990 | 108 | |
| 4 | 1990 | 105 | |
| 5 | 1988 | 105 | |
| 6 | 1992 | 104 | |
| 7 | 1998 | 89 | |
| 8 | 1997 | 57 | |
| 9 | 1995 | 54 | |
| 10 | 1993 | 50 | |
| 11 | 1998 | 44 | |
| 12 | 1989 | 43 | |
| 13 | 1995 | 35 | |
| 14 | 1988 | 34 | |
| 15 | 2000 | 31 | |
| 16 | 1987 | 30 | |
| 17 | 1993 | 25 | |
| 18 | 1992 | 20 | |
| 19 | 1994 | 19 | |
| 20 | 1986 | 17 |
About RS Camplejohn
RS Camplejohn is a scholar working on Oncology, Pathology and Forensic Medicine, Cancer Research, Molecular Biology and Radiology, Nuclear Medicine and Imaging, having authored 27 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (9 papers), Cancer-related Molecular Pathways (6 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), HER2/EGFR in Cancer Research (4 papers), Breast Lesions and Carcinomas (3 papers), Lymphoma Diagnosis and Treatment (3 papers), Genetic factors in colorectal cancer (3 papers) and Cutaneous Melanoma Detection and Management (2 papers). The work is most often cited by research in Cancer Research (378 citations), Oncology (664 citations), Pathology and Forensic Medicine (219 citations), Radiology, Nuclear Medicine and Imaging (180 citations) and Molecular Biology (416 citations). RS Camplejohn has collaborated with scholars based in United Kingdom, Thailand and Canada. Frequent co-authors include R. A. Walker, DM Barnes, D M Barnes, R R Millis, Jiřina Bártková, MA Richards, Martine E. Lomax, Steven M. Picksley, M A Richards and Julia A. Newton. Their work appears in journals such as British Journal of Cancer, Oncogene, British Journal of Dermatology, Clinical Oncology and Histopathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.